Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership1,247,447 shares
Latest Disclosed Value $ 164,338,668
Millennium Management Llc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 1,247,447 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $164,338,668 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 442,866 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 181.68% during the quarter.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,247,447 804,581 181.68 164,339 161.64 0.0684
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 442,866 -534,344 -54.68 62,812 -54.21 0.0264
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 977,210 -217,009 -18.17 137,181 -8.61 0.0586
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,194,219 617,629 107.12 150,101 135.38 0.0725
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 576,590 157,878 37.71 63,771 11.58 0.0339
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 418,712 105,945 33.87 57,154 58.60 0.0279
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 312,767 125,284 66.82 36,037 39.62 0.0171
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 187,483 -267,737 -58.81 25,811 -58.89 0.0120
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 455,220 -233,736 -33.93 62,784 -30.84 0.0268
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 688,956 -579,310 -45.68 90,777 -36.38 0.0393
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,268,266 418,008 49.16 142,680 77.95 0.0720
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 850,258 281,983 49.62 80,179 39.39 0.0395
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 568,275 -272,065 -32.38 57,521 -42.69 0.0330
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 840,340 267,284 46.64 100,370 64.91 0.0555
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 573,056 210,383 58.01 60,864 72.16 0.0360
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 362,673 -137,454 -27.48 35,353 -24.60 0.0219
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 500,127 -60,870 -10.85 46,887 -1.87 0.0249
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 560,997 69,753 14.20 47,780 1.41 0.0243
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 491,244 369,733 304.28 47,115 298.44 0.0283
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 121,511 121,511 11,825 0.0073
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -225,156 -100.00 0 -100.00
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 225,156 182,520 428.09 21,581 426.37 0.0156
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 42,636 -16,514 -27.92 4,100 -43.18 0.0050
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 59,150 -57,650 -49.36 7,216 -28.62 0.0099
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 116,800 -269,258 -69.75 10,109 -75.64 0.0227
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 386,058 109,006 39.34 41,497 66.22 0.0519
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 277,052 73,342 36.00 24,965 45.15 0.0395
2019-08-15 2019-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 203,710 -356,238 -63.62 17,199 -65.14 0.0259
2019-08-14 2019-06-30 13F OPEN TEXT COM 64125C109 715,005 -548,428 31,270
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 559,948 539,208 2,599.85 49,331 3,230.93 0.0738
2019-02-15 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 20,740 -337,795 -94.22 1,481 -96.64 0.0023
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,740 1,481
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 358,535 331,346 1,218.68 44,082 1,550.39 0.0540
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,189 -100,726 -78.74 2,671 -74.82 0.0035
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 127,915 -406,651 -76.07 10,608 -74.42 0.0142
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 534,566 417,661 357.27 41,477 478.96 0.0572
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 116,905 116,905 -78.13 7,164 -82.73 0.0109
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -1,335,798 -100.00 0 -100.00
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,335,798 1,227,830 1,137.22 51,695 845.58 0.1083
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 107,968 -506,608 -82.43 5,467 -80.43 0.0092
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 614,576 -474,339 -43.56 27,932 -35.14 0.0639
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,088,915 31,292 2.96 43,067 -28.02 0.1076
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,057,623 -267,751 -20.20 59,830 13.45 0.1258
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,325,374 168,487 14.56 52,737 -4.55 0.1021
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,156,887 -315,986 -21.45 55,253 -5.53 0.1045
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,472,873 251,207 20.56 58,488 114.30 0.1088
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,221,666 879,740 257.29 27,292 409.37 0.0578
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 341,926 -67,015 -16.39 5,358 -11.69 0.0136
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 408,941 -421,933 -50.78 6,067 -21.82 0.0168
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 830,874 765,874 1,178.27 7,760 954.35 0.0245
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 65,000 -15,819 -19.57 736 -31.91 0.0024
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 80,819 80,819 1,081 0.0033
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Call 46,600 556.34 5,154 431.79 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 7,100 969 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 107,500 14,800 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Call 60,000 -55.12 5,110 -60.15 n/a n/a n/a
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Call 133,700 -10.87 12,823 -12.16 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 150,000 0.00 14,598 0.07 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 150,000 1,239.29 14,588 1,258.29 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 11,200 -92.53 1,074 -92.64 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-15 2019-06-30 13F/A NEUROCRINE BIOSCIENCES COM Call 50,000 0.00 4,222 -4.15 n/a n/a n/a
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 50,000 4,405 n/a n/a n/a
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Call 80,000 60.00 3,096 22.27 n/a n/a n/a
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Call 50,000 0.00 2,532 11.39 n/a n/a n/a
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Call 50,000 0.00 2,273 -10.23 n/a n/a n/a
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Call 500,000 66.67 19,895 38.85 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM Call 300,000 -40.00 14,328 -27.98 n/a n/a n/a
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COM Call 75,400 -16.50 854 -29.30 n/a n/a n/a
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COM Call 90,300 1,208 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Put 50,700 7,117 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 8,800 -52.94 1,201 -44.24 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 18,700 2,155 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Put 15,000 1,688 n/a n/a n/a
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Put 200,000 7,740 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Put 100,000 0.00 3,971 77.75 n/a n/a n/a
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Put 100,000 2,234 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.